# Beta-Adrenergic Modulation of Drug Cue Reactivity

> **NCT05587361** · PHASE4 · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 80 (estimated)

## Conditions studied

- Tobacco Use Disorder
- Nicotine Dependence
- Cigarette Smoking

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Nicotine Patch
- **DRUG:** Placebo Propranolol
- **DRUG:** Placebo Patch

## Key facts

- **NCT ID:** NCT05587361
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-26
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- Oklahoma State University Center for Health Sciences
- Duke University
- National Institute on Drug Abuse (NIDA)
- National Institutes of Health (NIH)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587361, "Beta-Adrenergic Modulation of Drug Cue Reactivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05587361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*